Tailoring amphotericin B as an ionic liquid: An upfront strategy to potentiate the biological activity of antifungal drugs

Diego O. Hartmann, Karina Shimizu, Maika Rothkegel, Marija Petkovic, Ricardo Ferraz, Željko Petrovski, Luís C. Branco, José N. Canongia Lopes, Cristina Silva Pereira

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
11 Downloads (Pure)


Aspergillus species are the primary cause of invasive aspergillosis, which afflicts hundreds of thousands of patients yearly, with high mortality rates. Amphotericin B is considered the gold standard in antifungal drug therapy, due to its broad-spectrum activity and rarely reported resistance. However, low solubility and permeability, as well as considerable toxicity, challenge its administration. Lipid formulations of amphotericin B have been used to promote its slow release and diminish toxicity, but these are expensive and adverse health effects of their prolonged use have been reported. In the past decades, great interest emerged on converting biologically active molecules into an ionic liquid form to overcome limitations such as low solubility or polymorphisms. In this study, we evaluated the biological activity of novel ionic liquid formulations where the cholinium, cetylpyridinium or trihexyltetradecylphosphonium cations were combined with an anionic form of amphotericin B. We observed that two formulations increased the antifungal activity of the drug, while maintaining its mode of action. Molecular dynamics simulations showed that higher biological activity was due to increased interaction of the ionic liquid with the fungal membrane ergosterol compared with amphotericin B alone. Increased cytotoxicity could also be observed, probably due to greater interaction of the cation with cholesterol, the main sterol in animal cells. Importantly, one formulation also displayed antibacterial activity (dual functionality), likely preserved from the cation. Collectively, the data set ground for the guided development of ionic liquid formulations that could improve the administration, efficacy and safety of antifungal drugs or even the exploitation of their dual functionality. This journal is

Original languageEnglish
Pages (from-to)14441-14452
Number of pages12
JournalRSC Advances
Issue number24
Publication statusPublished - 12 Apr 2021


Dive into the research topics of 'Tailoring amphotericin B as an ionic liquid: An upfront strategy to potentiate the biological activity of antifungal drugs'. Together they form a unique fingerprint.

Cite this